FDA published Manual of Policies and Procedures (MAPP 5221.3), “Using Four-Part Harmony in OGD-Related Assessment Communications.” This external MAPP describes how Office of Generic Drugs (OGD) assessors can follow the principles of Four-Part Harmony to enhance the clarity of OGD-related communications sent to applicants during assessments across the product life cycle.